WASHINGTON, DC (January 29, 2019): The Council for Affordable Health Coverage (CAHC) – a coalition of employers, insurers, life science companies, PBMs, brokers, agents, patient groups, and physician organizations – responded today to a separate hearings on prescription drug affordability convened by both the Senate Finance Committee and the House Committee on Oversight and Reform.
“As Congress continues to explore the many factors contributing to the cost of medicines, we must focus on proven, market-based policies that lower costs and protect patient access while avoiding government-run policies with unintended consequences,” said CAHC President Joel White. “CAHC has been a leader in bringing diverse stakeholders together around solutions that reward value, spur greater competition among manufacturers, and address government-imposed pricing floors that inhibit steep discounting like the flawed Medicaid ‘best price’ law. Indeed, we are working closely with our champions in the Senate toward the introduction of bipartisan, cost-saving legislation to advance value-based payment models in federal health programs as we speak. While others in Washington point fingers, we will continue the important work of advancing commonsense, market-driven affordability solutions.”
About the Council for Affordable Health Coverage
The Council for Affordable Health Coverage (CAHC) is a broad-based alliance with a primary focus: bringing down the cost of health care for all Americans. CAHC promotes policies that lower health costs through increased competition, informed consumers and more choices. Learn more at CAHC.net.